These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9564639)

  • 1. "Add-back" therapy for endometriosis in adolescents.
    Lubianca JN; Gordon CM; Laufer MR
    J Reprod Med; 1998 Mar; 43(3):164-72. PubMed ID: 9564639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current approaches to optimizing the treatment of endometriosis in adolescents.
    Laufer MR
    Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis.
    Gargiulo AR; Hornstein MD
    Semin Reprod Endocrinol; 1997; 15(3):273-84. PubMed ID: 9383836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
    Surrey ES
    Curr Opin Obstet Gynecol; 2010 Aug; 22(4):283-8. PubMed ID: 20498596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Add-back therapy in the treatment of endometriosis-associated pain.
    Zupi E; Marconi D; Sbracia M; Zullo F; De Vivo B; Exacustos C; Sorrenti G
    Fertil Steril; 2004 Nov; 82(5):1303-8. PubMed ID: 15533351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone densitometry as an adjunct to GnRH agonist therapy.
    Cann CE
    J Reprod Med; 1998 Mar; 43(3 Suppl):321-30. PubMed ID: 9564668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications.
    Agarwal SK
    J Reprod Med; 1998 Mar; 43(3 Suppl):293-8. PubMed ID: 9564664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal therapies for endometriosis: implications for bone metabolism.
    Dawood MY
    Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A meta-analysis of preventing bone mineral loss in patients with endometriosis treated by gonadotrophin-releasing hormone analogues with add-back therapy].
    Niu ZR; Yue XJ; Kong QY; Wang YF; Yao YQ
    Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):338-43. PubMed ID: 24016475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.
    DiVasta AD; Feldman HA; Sadler Gallagher J; Stokes NA; Laufer MR; Hornstein MD; Gordon CM
    Obstet Gynecol; 2015 Sep; 126(3):617-627. PubMed ID: 26181088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the management of endometriosis: an update for clinicians.
    Crosignani P; Olive D; Bergqvist A; Luciano A
    Hum Reprod Update; 2006; 12(2):179-89. PubMed ID: 16280355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density?
    Agarwal SK
    J Reprod Med; 2002 Jul; 47(7):530-4. PubMed ID: 12170527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen-progesterone "add-back" for long-term GNRH analogue therapy].
    Levy T; Ben-Rafael Z
    Harefuah; 1995 Jun; 128(12):789-92. PubMed ID: 7557691
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of endometriosis].
    Römer T
    Med Monatsschr Pharm; 2012 Feb; 35(2):44-51; quiz 53-4. PubMed ID: 22400429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for add-back with gonadotrophin-releasing hormone agonist therapy.
    Studd J; Leather AT
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():1-4. PubMed ID: 8916978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient.
    Surrey ES
    Fertil Steril; 1995 Oct; 64(4):673-85. PubMed ID: 7672133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis.
    Wu D; Hu M; Hong L; Hong S; Ding W; Min J; Fang G; Guo W
    Arch Gynecol Obstet; 2014 Sep; 290(3):513-23. PubMed ID: 24728145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GnRH agonist and add back therapy--indications, results and problems in the treatment of genital endometriosis].
    Mettler L
    Zentralbl Gynakol; 2003; 125(7-8):267-75. PubMed ID: 14505262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis.
    Chwalisz K; Surrey E; Stanczyk FZ
    Reprod Sci; 2012 Jun; 19(6):563-71. PubMed ID: 22457429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.